RESTRUX

Welcome to the Brand page for “RESTRUX”, which is offered here for Human cadaveric bone tissue intended for subsequent implantation in a patient; human cadaveric bone tissue, cleaned and processed to remove cellular elements, intended for subsequent implantation into a patient to correct a defect or injury; cadaveric tissue grafts in the nature of processed cadaveric bone grafts; human allograft tissue used to stimulate new bone formation in spine, orthopedic, and trauma surgical applications; all of the foregoing excluding intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy;restruct;.

Its status is currently believed to be active. Its class is unavailable. “RESTRUX” is believed to be currently owned by “CoreLink, LLC”.


Owner:
CORELINK, LLC
Owner Details
Description:
Human cadaveric bone tissue intended for subsequent implantation in a patient; human cadaveric bone tissue, cleaned and processed to remove cellular elements, intended for subsequent implantation into a patient to correct a defect or injury; cadaveric tissue grafts in the nature of processed cadaveric bone grafts; human allograft tissue used to stimulate new bone formation in spine, orthopedic, and trauma surgical applications; all of the foregoing excluding intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy;RESTRUCT;
Categories: HUMAN CADAVERIC BONE TISSUE INTENDED